Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

No reported Deferred Tax Liabilities figures are available to summarize.

Deferred Tax Liabilities history

Currency unavailable · from the balance sheet

No Deferred Tax Liabilities data reported for this period type.

Deferred Tax Liabilities vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Deferred Tax Liabilities for LTGO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PCRXPacira BioSciences, Inc.Mar 2026$4.09M USD-41.5%—0.3%
COLLCollegium Pharmaceutical, Inc.Mar 2026$0 USD——0.0%
SCLXScilex Holding CompanyMar 2026$0 USD——0.0%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —-41.5%—0.0%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.